2021
Association of clinical characteristics, antidiabetic and cardiovascular agents with diabetes mellitus and COVID-19: a 7-month follow-up cohort study
Pazoki M, Chichagi F, Hadadi A, Kafan S, Montazeri M, Kazemian S, Aminorroaya A, Ebrahimi M, Ashraf H, Hazaveh M, Khajavi M, Moharari R, Sharifnia S, Saleh S, Rahimzadeh H, Goodarzi N, Heydarian P. Association of clinical characteristics, antidiabetic and cardiovascular agents with diabetes mellitus and COVID-19: a 7-month follow-up cohort study. Journal Of Diabetes & Metabolic Disorders 2021, 20: 1545-1555. PMID: 34778117, PMCID: PMC8573568, DOI: 10.1007/s40200-021-00901-4.Peer-Reviewed Original ResearchAssociated with borderlineUnivariate analysisRisk of in-hospital adverse outcomesDiabetes mellitusPreadmission usePrognostic factors of long-term outcomeAssociation of clinical characteristicsIn-hospital adverse outcomesFactors of long-term outcomeBorderline increased riskRetrospective cohort studyIn-hospital complicationsLong-term outcomesRisk of MAEAll-cause mortalityIn-hospital deathSevere COVID-19Risk of severityClinical characteristicsEvaluating patientsAdverse eventsLogistic regression modelsCohort studyAdverse outcomesHospitalized patients
2020
Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19
Soleimani A, Kazemian S, Saleh S, Aminorroaya A, Shajari Z, Hadadi A, Talebpour M, Sadeghian H, Payandemehr P, Sotoodehnia M, Bahreini M, Najmeddin F, Heidarzadeh A, Zivari E, Ashraf H. Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19. American Journal Of Hypertension 2020, 33: 1102-1111. PMID: 32920644, PMCID: PMC7543264, DOI: 10.1093/ajh/hpaa149.Peer-Reviewed Original ResearchConceptsAngiotensin II receptor blockersAngiotensin-converting enzyme inhibitorsIn-hospital outcomesAcute kidney injuryClinically suspected COVID-19Severe COVID-19Receptor blockersEffects of angiotensin receptor blockersWorld Health Organization interim guidanceBenefits of angiotensin-converting enzyme inhibitorsIn-hospital outcomes of patientsAssociated with poor in-hospital outcomesFollowed-up patientsPoor in-hospital outcomesOutcomes of patientsAngiotensin receptor blockersII receptor blockersRetrospective observational studyIn-hospital complicationsIncomplete medical recordsRisk of mortalityClinical suspicionInvasive ventilationHypertensive patientsKidney injury